Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BREIMER, D. D")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 208

  • Page / 9

Export

Selection :

  • and

Interindividual variations in drug disposition: clinical implications and methods of investigationBREIMER, D. D.Clinical pharmacokinetics. 1983, Vol 8, Num 5, pp 371-377, issn 0312-5963Article

An integrated pharmacokinetic and pharmacodynamic approach to controlled drug deliveryBREIMER, D. D.Journal of drug targeting. 1996, Vol 3, Num 6, pp 411-415, issn 1061-186XArticle

In vivo function tests of hepatic drug-oxidizing capacity in patients with liver diseaseTANAKA, E; BREIMER, D. D.Journal of clinical pharmacy and therapeutics (Print). 1997, Vol 22, Num 4, pp 237-249, issn 0269-4727Article

Future challenges for drug deliveryBREIMER, D. D.Journal of controlled release. 1999, Vol 62, Num 1-2, pp 3-6, issn 0168-3659Conference Paper

Future challenges for drug delivery researchBREIMER, D. D.Advanced drug delivery reviews. 1998, Vol 33, Num 3, pp 265-268, issn 0169-409XArticle

Relevance of the application of pharmacokinetic-pharmacodynamic modelling concepts in drug development : The 'wooden shoe' paradigmBREIMER, D. D; DANHOF, M.Clinical pharmacokinetics. 1997, Vol 32, Num 4, pp 259-267, issn 0312-5963Article

The CED-le DEC : Common European doctorate, or doctorate Europeen commune or dissertations on the InternetBREIMER, L. H; BREIMER, D. D.Scientometrics (Print). 1996, Vol 35, Num 3, pp 347-353, issn 0138-9130Article

The blood-brain barrier : clinical implications for drug delivery to the brainDE BOER, A. G; BREIMER, D. D.Journal of the Royal College of Physicians of London. 1994, Vol 28, Num 6, pp 502-506, issn 0035-8819Article

Microsomal and cytosolic epoxide hydrolase in Drosophila melanogasterJANSEN, M; BAARS, A. J; BREIMER, D. D et al.Biochemical pharmacology. 1986, Vol 35, Num 13, pp 2229-2232, issn 0006-2952Article

Application of pharmacokinetic/pharmacodynamic modelling and population approaches to drug developmentJOCHEMSEN, R; LAVEILLE, C; BREIMER, D. D et al.International journal of pharmaceutical medicine. 1999, Vol 13, Num 5, pp 243-251, issn 1364-9027Article

Gas chromatographic analysis of nitrendipine and its pyridine metabolite in human plasmaSOONS, P. A; BREIMER, D. D.Journal of chromatography. 1988, Vol 428, Num 2, pp 362-368, issn 0021-9673Article

Cytosolic glutathione S-transferases in Drosophila melanogasterJANSEN, M; BAARS, A. J; BREIMER, D. D et al.Biochemical pharmacology. 1984, Vol 33, Num 22, pp 3655-3659, issn 0006-2952Article

Pharmacokinetic-pharmacodynamic modeling of CNS drug effects: an overviewDINGEMANSE, J; DANHOF, M; BREIMER, D. D et al.Pharmacology & therapeutics (Oxford). 1988, Vol 38, Num 1, pp 1-52, issn 0163-7258Article

Stereoselective pharmacokinetics of oral and intravenous nitrendipine in healthy male subjectsSOONS, P. A; BREIMER, D. D.British journal of clinical pharmacology. 1991, Vol 32, Num 1, pp 11-16, issn 0306-5251, 6 p.Article

Microsomal and cytosolic epoxide hydrolase in Drosophila melanogasterJANSEN, M; BAARS, A. J; BREIMER, D. D et al.Biochemical pharmacology. 1986, Vol 35, Num 13, pp 2229-2232, issn 0006-2952Article

Rectal, oral and I. A. administration of etomidate to rats : significant avoidance of hepatic first-pass elimination following rectal administrationDE BOER, A. G; BREIMER, D. D.Archives internationales de pharmacodynamie et de thérapie. 1984, Vol 270, Num 2, pp 180-191, issn 0003-9780Article

Effects of acute febrile infectious diseases on the oral pharmacokinetics and effects of nitrendipine enantiomers and of bisoprololSOONS, P. A; GRIB, C; BREIMER, D. D et al.Clinical pharmacokinetics. 1992, Vol 23, Num 3, pp 238-248, issn 0312-5963Article

Effects of single-dose and short-term oral nifedipine on indocyanine green clearance as assessed by spectrophotometry and high performance liquid chromatographySOONS, P. A; KROON, J. M; BREIMER, D. D et al.Journal of clinical pharmacology. 1990, Vol 30, Num 8, pp 693-698, issn 0091-2700, 6 p.Article

Lack of bimodality in nifedipine plasma kinetics in a large population of healthy subjectsSCHELLENS, J. H. M; SOONS, P. A; BREIMER, D. D et al.Biochemical pharmacology. 1988, Vol 37, Num 13, pp 2507-2510, issn 0006-2952Article

Pharmacokinetics of rectal drug administration. I, General considerations and clinical applications of centrally acting drugsVAN HOOGDALEM, E. J; DE BOER, A. G; BREIMER, D. D et al.Clinical pharmacokinetics. 1991, Vol 21, Num 1, pp 11-26, issn 0312-5963, 16 p.Article

Comparative effects of felodipine, nitrendipine and nifedipine in healthy subjects : concentration-effect ralationships of racemic drugs and enantiomersSOONS, P. A; COHEN, A. F; BREIMER, D. D et al.European journal of clinical pharmacology. 1993, Vol 44, Num 2, pp 113-120, issn 0031-6970Article

Influence of the rate of hepatic portal vein infusion on hexobarbital pharmacokinetics in the ratJOERES, R. P; VERMEULEN, N. P. E; BREIMER, D. D et al.Pharmacology. 1988, Vol 36, Num 3, pp 210-216, issn 0031-7012Article

The transference of results between blood-brain barrier cell culture systemsDE BOER, A. G; GAILLARD, P. J; BREIMER, D. D et al.European journal of pharmaceutical sciences. 1999, Vol 8, Num 1, pp 1-4, issn 0928-0987Article

Monitoring in vivo blood-brain barrier drug transport : cerebrospinal fluid sampling, the unit impulse response method and, with special reference, intracerebral microdialysisDE LANGE, E. C. M; DE BOER, A. G; BREIMER, D. D et al.STP pharma sciences. 1997, Vol 7, Num 1, pp 17-27, issn 1157-1489Article

IV : Rate-controlled rectal peptide drug absorption enhancementDE BOER, A. G; VAN HOOGDALEM, E. J; BREIMER, D. D et al.Advanced drug delivery reviews. 1992, Vol 8, Num 2-3, pp 237-251, issn 0169-409XArticle

  • Page / 9